Quadrant Capital Group’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-735
| Closed | -$1.62K | – | 2774 |
|
|
2024
Q4 | $1.62K | Hold |
735
| – | – | ﹤0.01% | 2524 |
|
|
2024
Q3 | $1.21K | Buy |
735
+300
| +69% | +$495 | ﹤0.01% | 2565 |
|
|
2024
Q2 | $966 | Buy |
+435
| New | +$966 | ﹤0.01% | 2568 |
|
|
2023
Q2 | – | Sell |
-386
| Closed | -$614 | – | 2714 |
|
|
2023
Q1 | $614 | Sell |
386
-573
| -60% | -$911 | ﹤0.01% | 2580 |
|
|
2022
Q4 | $5.98K | Sell |
959
-554
| -37% | -$3.45K | ﹤0.01% | 2166 |
|
|
2022
Q3 | $10K | Buy |
1,513
+844
| +126% | +$5.58K | ﹤0.01% | 1886 |
|
|
2022
Q2 | $4K | Buy |
669
+549
| +458% | +$3.28K | ﹤0.01% | 2027 |
|
|
2022
Q1 | $1K | Buy |
120
+13
| +12% | +$108 | ﹤0.01% | 2289 |
|
|
2021
Q4 | $1K | Buy |
+107
| New | +$1K | ﹤0.01% | 2291 |
|
|
2021
Q3 | – | Sell |
-21
| Closed | – | – | 2536 |
|
|
2021
Q2 | $0 | Buy |
+21
| New | – | ﹤0.01% | 2446 |
|
|
2016
Q3 | – | Sell |
-377
| Closed | -$3K | – | 2016 |
|
|
2016
Q2 | $3K | Buy |
+377
| New | +$3K | ﹤0.01% | 1336 |
|